Eli Lilly pauses trial of antibody drug Trump touted as Covid-19 'cure' over safety concern

  • 📰 The Straits Times
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 63%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

WASHINGTON (REUTERS) - Eli Lilly and Co said on Tuesday (Oct 13) that the US government-sponsored clinical trial of its Covid-19 antibody treatment similar to one taken by President Donald Trump has been paused because of a safety concern.. Read more at straitstimes.com.

WASHINGTON - Eli Lilly and Co said on Tuesday that the US government-sponsored clinical trial of its Covid-19 antibody treatment similar to one taken by President Donald Trump has been paused because of a safety concern.

AstraZeneca Plc's US trial for its experimental Covid-19 vaccine has also been on hold for over a month after a volunteer in its UK study fell ill. Trials of that vaccine resumed in other regions after a brief halt. "Out of an abundance of caution, the ACTIV-3 independent data safety monitoring board has recommended a pause in enrollment," Lilly spokesperson Molly McCully said in an e-mailed statement.

The US Food and Drug Administration and the National Institutes of Health did not immediately reply to requests for comment.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eli Lilly COVID-19 antibody trial paused due to potential safety concernUS drugmaker Eli Lilly and Co said on Tuesday (Oct 13) that the government-sponsored clinical trial of its COVID-19 antibody treatment has been ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Eli Lilly antibody trial paused due to potential safety concernU.S. drugmaker Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment has been paused ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Eli Lilly COVID-19 antibody trial paused due to potential safety concernUS drugmaker Eli Lilly and Co said on Tuesday (Oct 13) that the government-sponsored clinical trial of its COVID-19 antibody treatment has been ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Eli Lilly antibody trial paused due to potential safety concernU.S. drugmaker Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment has been paused ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »